M. Stelt

Endocannabinoids and β-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels

V. Marzo, F. Drago, I. Matias, 2006, Cellular and Molecular Life Sciences CMLS.

The Endocannabinoid Anandamide : Metabolism & Neuroprotection

M. Stelt, 2002 .

In vitro and in vivo pharmacology of synthetic olivetol‐ or resorcinol‐derived cannabinoid receptor ligands

T. Bisogno, V. Di Marzo, R. Pertwee, 2006, British journal of pharmacology.

Exogenous Anandamide Protects Rat Brain against Acute Neuronal Injury In Vivo

K. Nicolay, T. Bisogno, V. Marzo, 2001, The Journal of Neuroscience.

Neuroprotection by the Endogenous Cannabinoid Anandamide and Arvanil against In Vivo Excitotoxicity in the Rat: Role of Vanilloid Receptors and Lipoxygenases

K. Nicolay, V. Marzo, W. Veldhuis, 2003, The Journal of Neuroscience.

Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity

K. Nicolay, W. Veldhuis, J. Vliegenthart, 2001, The Journal of Neuroscience.